{"id":"human-rotavirus-live-attenuated","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Irritability"},{"rate":null,"effect":"Loss of appetite"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains weakened (attenuated) rotavirus strains that can replicate in the intestinal epithelium but have reduced virulence. This replication triggers both mucosal and systemic immune responses, including the production of neutralizing antibodies and cellular immunity against rotavirus antigens. The attenuated virus provides protection against wild-type rotavirus infection while minimizing the risk of vaccine-strain disease.","oneSentence":"A live attenuated rotavirus vaccine that replicates in the intestinal tract to stimulate immune responses against rotavirus without causing severe disease.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:47:11.209Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of rotavirus gastroenteritis in infants and young children"}]},"trialDetails":[{"nctId":"NCT06331156","phase":"PHASE3","title":"A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-03-22","conditions":"Gastroenteritis","enrollment":400},{"nctId":"NCT04429295","phase":"PHASE3","title":"Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-06-28","conditions":"Pertussis Immunisation, Diphtheria Immunisation, Polio Immunisation","enrollment":460},{"nctId":"NCT06879327","phase":"PHASE2","title":"Infant Malaria Vaccine Schedule Optimization","status":"RECRUITING","sponsor":"PATH","startDate":"2025-05-30","conditions":"Malaria Vaccines","enrollment":1200},{"nctId":"NCT04658914","phase":"PHASE2","title":"Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2021-04-15","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":720},{"nctId":"NCT06025695","phase":"PHASE3","title":"Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-09-01","conditions":"Gastroenteritis","enrollment":2000},{"nctId":"NCT02941107","phase":"PHASE4","title":"Optimising Rotavirus Vaccine in Aboriginal Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2018-03-27","conditions":"Viral Gastroenteritis Due to Rotavirus","enrollment":1000},{"nctId":"NCT02145000","phase":"PHASE3","title":"Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger","status":"COMPLETED","sponsor":"Epicentre","startDate":"2014-06","conditions":"Severe Rotavirus Gastroenteritis","enrollment":6586},{"nctId":"NCT03954743","phase":"PHASE3","title":"Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-07-19","conditions":"Infections, Rotavirus","enrollment":1351},{"nctId":"NCT05037435","phase":"PHASE3","title":"Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.","status":"COMPLETED","sponsor":"Limited Liability Company Pharm Aid","startDate":"2018-06-25","conditions":"Rotavirus Infections, Rotavirus Vaccines","enrollment":40},{"nctId":"NCT05032391","phase":"PHASE3","title":"Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization","status":"COMPLETED","sponsor":"Limited Liability Company Pharm Aid","startDate":"2019-02-22","conditions":"Rotavirus Infection","enrollment":100},{"nctId":"NCT00353366","phase":"","title":"To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11-16","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":1439},{"nctId":"NCT03703336","phase":"PHASE3","title":"Phase III Study of Liquid Formulation of ROTAVIN","status":"COMPLETED","sponsor":"Center for Research and Production of Vaccines and Biologicals, Vietnam","startDate":"2019-03-16","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":825},{"nctId":"NCT03207750","phase":"PHASE3","title":"This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-09-14","conditions":"Rotavirus Infection, Rotavirus Vaccines","enrollment":1280},{"nctId":"NCT03602053","phase":"PHASE2, PHASE3","title":"Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2019-01-22","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":450},{"nctId":"NCT02141204","phase":"PHASE3","title":"Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-02-20","conditions":"Rotavirus","enrollment":451},{"nctId":"NCT00263666","phase":"PHASE2","title":"A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-03-16","conditions":"Infections, Rotavirus","enrollment":100},{"nctId":"NCT04596696","phase":"PHASE3","title":"Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam","status":"COMPLETED","sponsor":"Bharat Biotech International Limited","startDate":"2017-12-20","conditions":"Rotavirus Gastroenteritis","enrollment":360},{"nctId":"NCT00750893","phase":"","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-09-02","conditions":"Infections, Rotavirus","enrollment":3111},{"nctId":"NCT01177826","phase":"","title":"Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-23","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":643},{"nctId":"NCT00432380","phase":"PHASE2","title":"A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-03-09","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":375},{"nctId":"NCT00140673","phase":"PHASE3","title":"A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-08-05","conditions":"Infections, Rotavirus","enrollment":63227},{"nctId":"NCT02907216","phase":"PHASE4","title":"Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-09-16","conditions":"Rotavirus","enrollment":292},{"nctId":"NCT04123119","phase":"NA","title":"Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2019-01-22","conditions":"Diarrhoeal Disease","enrollment":22},{"nctId":"NCT02286895","phase":"PHASE4","title":"Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali","status":"COMPLETED","sponsor":"PATH","startDate":"2014-10","conditions":"Diarrhea Rotavirus","enrollment":600},{"nctId":"NCT02584816","phase":"PHASE3","title":"Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2015-11","conditions":"Rotavirus Gastroenteritis","enrollment":1500},{"nctId":"NCT02133690","phase":"PHASE3","title":"A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2014-05","conditions":"Rotavirus Gastroenteritis","enrollment":7500},{"nctId":"NCT00779779","phase":"","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-22","conditions":"Infections, Rotavirus","enrollment":522},{"nctId":"NCT00420316","phase":"PHASE3","title":"Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-02-12","conditions":"Infections, Rotavirus","enrollment":1613},{"nctId":"NCT01198769","phase":"PHASE4","title":"Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-11","conditions":"Infections, Rotavirus","enrollment":15},{"nctId":"NCT01171963","phase":"PHASE3","title":"Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08-29","conditions":"Infections, Rotavirus","enrollment":3340},{"nctId":"NCT00420745","phase":"PHASE3","title":"To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-25","conditions":"Infections, Rotavirus","enrollment":1009},{"nctId":"NCT00158756","phase":"PHASE3","title":"Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09-12","conditions":"Hepatitis B","enrollment":308},{"nctId":"NCT00938327","phase":"","title":"Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-08-03","conditions":"Infections, Rotavirus","enrollment":332},{"nctId":"NCT02728869","phase":"PHASE1, PHASE2","title":"Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants","status":"COMPLETED","sponsor":"MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.","startDate":"2016-06","conditions":"Rotavirus Gastroenteritis","enrollment":100},{"nctId":"NCT00289172","phase":"PHASE3","title":"Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-02-10","conditions":"Infections, Rotavirus","enrollment":360},{"nctId":"NCT01107587","phase":"PHASE1","title":"Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-04-13","conditions":"Infections, Rotavirus","enrollment":50},{"nctId":"NCT01511133","phase":"","title":"Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-04","conditions":"Rotavirus Infection, Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants","enrollment":1},{"nctId":"NCT00140686","phase":"PHASE3","title":"To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-09","conditions":"Infections, Rotavirus","enrollment":3994},{"nctId":"NCT00169455","phase":"PHASE3","title":"Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-03","conditions":"Rotavirus Gastroenteritis","enrollment":450},{"nctId":"NCT00241644","phase":"PHASE3","title":"Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Infections, Rotavirus","enrollment":2089},{"nctId":"NCT00329745","phase":"PHASE3","title":"Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01","conditions":"Infections, Rotavirus","enrollment":8687},{"nctId":"NCT00197210","phase":"PHASE3","title":"A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-12","conditions":"Infections, Rotavirus","enrollment":10708},{"nctId":"NCT00334607","phase":"PHASE3","title":"Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-06","conditions":"Infections, Rotavirus","enrollment":484},{"nctId":"NCT00382772","phase":"PHASE3","title":"A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11","conditions":"Infections, Rotavirus","enrollment":1200},{"nctId":"NCT00139347","phase":"PHASE3","title":"Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-12","conditions":"Infections, Rotavirus","enrollment":6360},{"nctId":"NCT00345956","phase":"PHASE3","title":"To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09","conditions":"Infections, Rotavirus","enrollment":375},{"nctId":"NCT00134732","phase":"PHASE3","title":"Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-07","conditions":"Infections, Rotavirus","enrollment":150},{"nctId":"NCT00137930","phase":"PHASE2","title":"Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-08","conditions":"Infections, Rotavirus","enrollment":250},{"nctId":"NCT00429481","phase":"PHASE2","title":"Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-01","conditions":"Hepatitis B","enrollment":2464},{"nctId":"NCT00425737","phase":"PHASE2","title":"Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-08","conditions":"Infections, Rotavirus","enrollment":405},{"nctId":"NCT00729001","phase":"PHASE2","title":"Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-11","conditions":"Infections, Rotavirus","enrollment":529},{"nctId":"NCT00383903","phase":"PHASE2","title":"Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-09","conditions":"Infections, Rotavirus","enrollment":472},{"nctId":"NCT00346892","phase":"PHASE2","title":"To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-11","conditions":"Rotavirus Infections","enrollment":450},{"nctId":"NCT01377571","phase":"PHASE2","title":"A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"National Institute of Hygiene and Epidemiology, Vietnam","startDate":"2009-10","conditions":"Diarrhea, Fever, Nausea","enrollment":200},{"nctId":"NCT01266850","phase":"PHASE4","title":"Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-03","conditions":"Rotavirus Infection","enrollment":1384},{"nctId":"NCT01091298","phase":"PHASE1","title":"A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers","status":"COMPLETED","sponsor":"Shantha Biotechnics Limited","startDate":"2010-04","conditions":"Rotavirus Gastroenteritis","enrollment":20},{"nctId":"NCT01061658","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine","status":"UNKNOWN","sponsor":"Shantha Biotechnics Limited","startDate":"2010-07","conditions":"Rotavirus Gastroenteritis","enrollment":90},{"nctId":"NCT00757926","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants","status":"WITHDRAWN","sponsor":"Shantha Biotechnics Limited","startDate":"2009-09","conditions":"Rotavirus Infections","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":308,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Rotarix™"],"phase":"phase_3","status":"active","brandName":"Human Rotavirus, live attenuated","genericName":"Human Rotavirus, live attenuated","companyName":"Sanofi Pasteur, a Sanofi Company","companyId":"sanofi","modality":"Biologic","firstApprovalDate":"","aiSummary":"A live attenuated rotavirus vaccine that replicates in the intestinal tract to stimulate immune responses against rotavirus without causing severe disease. Used for Prevention of rotavirus gastroenteritis in infants and young children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}